Oxaliplatin in Rectal Cancer

The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to potential participation in the trial, or to replace the advice of a personal physician or health professional. Main criteria are listed hereafter: Inclusion Criteria: ECOG: 0-2 Histological proved rectal adenocarcinoma No chemotherapy treatment on the previous 6 months before inclusion. No previous pelvic radiotherapy treatment Exclusion Criteria: Important Biological abnormality (renal, hepatic and/or hematological) Intestinal occlusion or subocclusion Peripheral neuropathy Pregnant or breast-feeding women. Potential child-bearing women with a positive pregnancy test. Participation in other trials on the previous 4 months.